A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/1999
12/02/1999	WO1999061049A2 Model for infection by a pathogen using administration of nucleic acids
12/02/1999	WO1999061048A1 CORRELATIVE PROTECTION USING OspA ANTIBODY TITERS
12/02/1999	WO1999061046A1 Parasite antigens
12/02/1999	WO1999053958A3 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with prostaglandin inhibitor
12/02/1999	WO1999052548A3 Conjugate vaccines for the prevention of dental caries
12/02/1999	WO1999051745A3 Dna immunization against chlamydia infection
12/02/1999	WO1999051268A9 Immunomodulatory compositions of mmtv antigens and methods of using same
12/02/1999	WO1999050424A3 Fusion protein comprising a sequence from a major coat protein of a papovavirus
12/02/1999	WO1999048518A3 Medicament for preventing or treating papilloma virus-specific tumors
12/02/1999	WO1999044636A3 Il-12 enhancement of immune responses to t-independent antigens
12/02/1999	WO1999043286A3 Isolated stromal cells for use in the treatment of diseases of the central nervous system
12/02/1999	WO1999040115A3 COMPOSITIONS AND METHODS TO INHIBIT FORMATION OF THE C5b-9 COMPLEX OF COMPLEMENT
12/02/1999	WO1999032634A3 Compositions derived from mycobacterium vaccae and methods for their use
12/02/1999	WO1999019354A9 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof
12/02/1999	DE19824230A1 Neues Endometriose-assoziiertes Gen Create an endometriosis-associated gene
12/02/1999	DE19823391A1 Polymers to which immunoadjuvants are fixed, useful, e.g., for rendering medical materials bacteria-free
12/02/1999	CA2333167A1 Method for purification of borrelia lipoprotein ospa
12/02/1999	CA2332979A1 Correlative protection using ospa antibody titers
12/02/1999	CA2332963A1 Combination meningitidis b/c vaccines
12/02/1999	CA2332786A1 Identification of broadly reactive dr restricted epitopes
12/02/1999	CA2331833A1 Parasite antigens
12/02/1999	CA2329269A1 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
12/02/1999	CA2329136A1 Oral immunization with papillomavirus virus-like particles
12/02/1999	CA2329076A1 Human hydrolase homologs: n-terminal asparagine amidohydrolase, glycosyl hydrolase, glucohydrolase, biotinidase, and n-acetylglucosamine 6-p deacetylase
12/02/1999	CA2329053A1 Human socs proteins
12/02/1999	CA2329052A1 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
12/02/1999	CA2328894A1 Methods and products for inducing mucosal immunity
12/02/1999	CA2328604A1 Compositions and methods of modulating an immune response to an antigen
12/02/1999	CA2328451A1 Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4
12/02/1999	CA2298070A1 Gene sequences of rubella virus associated with attenuation
12/01/1999	EP0960936A1 Reconstituted human anti-hm1.24 antibody
12/01/1999	EP0960887A1 T cell epitope peptide
12/01/1999	EP0960337A1 Cathepsin K and breast cancer
12/01/1999	EP0960334A1 Vegf-b/receptor complex and uses thereof
12/01/1999	EP0960208A1 Glutathione s-transferase (gst) genes in cancer
12/01/1999	EP0960205A1 Chain reaction cloning
12/01/1999	EP0960204A1 Method and reagents for genetic immunization
12/01/1999	EP0960192A1 Synthetic polynucleotides
12/01/1999	EP0960117A1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE
12/01/1999	EP0960115A1 MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS AN ONCOGENE
12/01/1999	EP0959905A2 Polysaccharide-peptide-conjugates
12/01/1999	EP0959903A1 NOVEL FabD
12/01/1999	EP0959902A1 Recombinant mycobacteria auxotrophic for diaminopimelate
12/01/1999	EP0959901A1 A method for generating birnavirus from synthetic rna transcripts
12/01/1999	EP0959900A1 Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using histone h1
12/01/1999	EP0959899A1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION
12/01/1999	EP0959895A1 Peptides responsive to antibodies against a consensus peptide of the cs4-cfa/i family proteins
12/01/1999	EP0959893A2 Stimulation of an immune response to a differentiation antigen stimulated by an altered antigen
12/01/1999	EP0755517B1 A method for detecting the presence of a mycobacterium species and a kit and antibodies for use therein
12/01/1999	EP0732937B1 Non-toxic mucosal adjuvant
12/01/1999	CN1237102A Liposomes
12/01/1999	CN1236646A Purified polyvalent vaccine of primary vole's kidney cells for epidemic hemorrhagic fever
12/01/1999	CN1046934C Acylfulvene analogues as antitumor agents
11/1999
11/30/1999	US5994525 Nucleic acid encoding Actinobacillus pleuropneumoniae cytolytic proteins
11/30/1999	US5994523 A nucleic acid molecule encoding a peptide comprising a sequence consisting of 8 contiguous amino acids of th mart-1(melanoma antigen recognized by t-cell-1) a preferential amino acid sequence which is capable of reacting tumor
11/30/1999	US5994516 Mutated proteins encoded by a lentivirus mutated env gene, peptide fragments and expression vectors
11/30/1999	US5994513 Oncoprotein protein kinase
11/30/1999	US5994511 Anti-IgE antibodies and methods of improving polypeptides
11/30/1999	US5994400 Reducing ph of aqueous solution; collecting precipitate; solubilizing
11/30/1999	US5994318 Complex; administering biologically active material
11/30/1999	US5994311 Using a oligopeptides, polypeptide
11/30/1999	US5994304 Polypeptide
11/30/1999	US5994301 Corpuscles of stannius protein, stanniocalcin
11/30/1999	US5994126 Obtaining dendritic cell precursors from tissue, culturing on a substrate in medium containing colony stimulating factor to obtain proliferating nonadherent mature cells; therapy for juvenile diabetes, autoimmune diseases, multiple sclerosis
11/30/1999	US5994116 Preparing a non-infectious viral particle having defects in its replication proteins; infecting cells with the virus and a chemical inhibitor of dna synthesis, preventing viral replication and recovering the desired particles; vaccines
11/30/1999	US5994115 Artificial system for the production of infectious human papillomavirus
11/30/1999	US5994112 A polynucleotide which codes a protein; antiproliferative agents, anticarcinogenic agents, antiinflammatory agents
11/30/1999	US5994111 A polypeptide; treatment and diagnosis of respiratory infections, septic arthritis, cardiovascular infections, gastrointestinal infections, toxic shock syndrome; antibiotics
11/30/1999	US5994108 A human enbryonic kidney cell line which produces increased levels of the human immunodefiency virus mutant stem-loop rna structure in the presence of a transactivation protein; vaccines for human immunodefiency virus
11/30/1999	US5994102 Polynucleotides encoding prostatic growth factor and process for producing prostatic growth factor polypeptides
11/30/1999	US5994101 DNA encoding gidA1 polypeptides
11/30/1999	US5994098 G protein coupled receptor gene; treatment of pain, diabetes, eating disorders, asthma; hypotensive/hypertensive agents; parkinson's/huntington's/cardiovascular diseases, ulcers, anticarcinogenic/antiallergens agents; osteoprosis,
11/30/1999	US5994096 Regulator
11/30/1999	US5994094 A bone morphogenetic protein; treatment of osteoporosis, prevent transplant rejection; wound healing agents; regeneration of bones, cartilage, connective tissue, skin, mucous membranes, epithelium and teeth
11/30/1999	US5994083 Collect serum samples from infected pateints with antibodies and a healthy individual, identify antibodies which bind antigens specific to the disease from phage library; select phages that display antigen recognized by antibody; vaccines
11/30/1999	US5993852 The immunogen is entrapped in lipid vesicles having a oil-in-water emulsion in the central core compartment.
11/30/1999	US5993829 Anti-cancer vaccine
11/30/1999	US5993828 Administering to the subject an effective dose of a composition comprising inactivated tumor cells having urinary tumor associated antigen on the cell surface and at least one tumor associated antigen
11/30/1999	US5993827 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins
11/30/1999	US5993826 Relates generally to various outer membrane proteins (omps) of moraxella catarrhalis for use as targets in immunotherapy
11/30/1999	US5993825 Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines
11/30/1999	US5993824 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
11/30/1999	US5993823 Cytotoxic T lymphocyte-inducing lipopeptides and methods of use
11/30/1999	US5993822 Modified live avian polymavirus vaccine in psittacine birds
11/30/1999	US5993821 Antigens and vaccines containing said vlps that may be effective in treatment of infections caused by such viruses.
11/30/1999	US5993820 The antigenic sequence is inserted into the ltb molecule by inserting the gene encoding the inhibin fragment into etxb at the unique sma i restriction site.
11/30/1999	US5993818 Use of autoantibodies for tumor therapy and prophylaxis
11/30/1999	US5993816 Methods to inhibit humoral immune responses, immunoglobulin production and B cell activation with 5c8-specific antibodies
11/30/1999	US5993814 Agents for inhibition of chemoattractant
11/30/1999	US5993812 Method of delaying the progression of an infection with the human immunodeficiency virus
11/30/1999	US5993811 Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis
11/30/1999	US5993783 Aerosols
11/30/1999	CA1340832C Recombinant cmv neutralizing proteins
11/25/1999	WO1999060171A1 Compounds, screening methods, and uses involving anti-apoptotic genes and gene products
11/25/1999	WO1999060153A2 Novel g-protein coupled receptor
11/25/1999	WO1999060135A1 Generation of multiple gene products from chimeric fusion proteins by cleavage with ubiquitous endoproteases
11/25/1999	WO1999060132A1 Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof
11/25/1999	WO1999060131A2 Hemorrhagic enteritis virus dna sequences, proteins encoded thereby and various uses thereof
11/25/1999	WO1999060125A2 Secreted proteins
11/25/1999	WO1999060124A2 Differentiation-associated sequences and methods of use therefor

1 ... 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 ... 1823